New surgical approach for rectal cancer in women aims to reduce bleeding
NCT ID NCT07189780
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This trial compares two surgical techniques for removing rectal cancer in women. The standard method cuts the peritoneum slightly above its lowest point, while the new method cuts exactly at the lowest point. Researchers believe the new technique may reduce blood loss and protect nearby structures. The study will enroll 200 women with mid-low rectal cancer who are scheduled for laparoscopic surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
surgical technique (precise peritoneal incision at the lowest point of the peritoneal reflection)
What this could lead to
If successful, this could establish a safer, more effective surgical approach for women with mid-low rectal cancer, reducing blood loss and improving recovery.
What could go wrong
This is an early-stage trial with only 200 participants, so results may not apply to all patients. The technique is a small change in procedure, so the benefits may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••